• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Pessoal
    • Webmail
    • Área de Docentes
    • Área de Não-Docentes
  • Estudantes
    • Webmail
    • Moodle
    • NetP@
    • Biblioteca
    • Escola Doutoral
    • Serviços Académicos
    • Trabalhar no IHMT

IHMT

Instituto de Higiene e Medicina Tropical

  • O Instituto
    • Missão
    • História
    • Mensagem do Diretor
    • Órgãos de governo
    • Docentes e investigadores
    • Unidades de Ensino e de Investigação
  • Ensino
    • Doutoramentos
    • Mestrados
    • Cursos de Especialização
    • Formação transversal
    • Cursos de Curta Duração
    • Ensino à Distância
    • Apoio ao Desenvolvimento
    • Serviços académicos
  • Investigação
    • Centro GHTM
    • Unidade de Clínica Tropical
    • Unidade de Microbiologia Médica
    • Unidade de Parasitologia Médica
    • Unidade de Saúde Internacional e Bioestatística
    • Serviço de Interesse Comum
    • Biobanco
    • Centro Colaborador da OMS
    • Publicações
  • Serviços e gestão
    • Biblioteca
    • Sistema de Qualidade
    • Estatutos e regulamentos
    • Relatórios
    • Contratos públicos
    • Recursos humanos
      • Concursos e bolsas
      • Mobilidade
  • Doenças Tropicais
    • Consulta do Viajante
    • Glossário
    • Museu
    • Vídeos
    • MosquitoWeb
  • Comunidade
    • Cooperação e Desenvolvimento
    • Formação
    • Parcerias
  • Contactos
  • Português
  • English
Home / Archives for 2012

2012

Ascorbic acid has superior ex vivo antiproliferative, cell death-inducing and immunomodulatory effects over IFN-α in HTLV-1-associated myelopathy.

  • Autores: Alvarez C, de Almeida Kruschewsky R, Decanine D, Galvão-Castro B, Gotuzzo E, Khouri R, López G, Menezes SM, Moens B, Silva-Santos G, Talledo M, Van Weyenbergh J, Vandamme AM
  • Ano de Publicação: 2012
  • Journal: Plos Neglected Tropical Diseases
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Ascorbic+Acid+Has+Superior+Ex+Vivo+Antiproliferative%2C+Cell+Death-Inducing+and+Immunomodulatory+Effects+over+IFN-alpha+in+HTLV-1-Associated+Myelopathy

BACKGROUND:
Clear therapeutic guidelines for HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) are missing due to the lack of randomized double-blind controlled clinical trials. Moderate yet similar clinical benefit has been demonstrated for IFN-α and high-dose ascorbic acid (AA) monotherapy in a large open clinical trial.
Ler mais

New insights on taxonomy, phylogeny and population genetics of Leishmania (Viannia) parasites based on multilocus sequence analysis.

  • Autores: Boité MC, Cupolillo E, Mauricio IL, Miles MA
  • Ano de Publicação: 2012
  • Journal: PLoS Negl Trop Dis
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=New+insights+on+taxonomy%2C+phylogeny+and+population+genetics+of+Leishmania+(Viannia)+parasites+based+on+multilocus+sequence+analysis

The Leishmania genus comprises up to 35 species, some with status still under discussion. The multilocus sequence typing (MLST)–extensively used for bacteria–has been proposed for pathogenic trypanosomatids. For Leishmania, however, a detailed analysis and revision on the taxonomy is still required.
Ler mais

In vitro and in vivo behaviour of sympatric Leishmania (V.) braziliensis, L. (V.) peruviana and their hybrids.

  • Autores: Campino L, Cortes S, Cristovao JM, Esteves C, Maia C, Mauricio I, Miles M
  • Ano de Publicação: 2012
  • Journal: Parasitology
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=In+vitro+and+in+vivo+behaviour+of+sympatric+Leishmania+(V.)+braziliensis%2C+L.+(V.)+peruviana+and+their+hybrids.

Leishmania (Viannia) braziliensis is the main cause of highly disfiguring mucocutaneous leishmaniasis (MCL) in South America. The related species L. (V.) peruviana has only been identified in simple cutaneous lesions (CL). Hybrids between L. braziliensis and L. peruviana have been reported although genetic exchange in Leishmania is considered to be rare. Here we compared growth in vitro, adaptive capacity under thermal and oxidative stress and behaviour in a hamster model, of L. braziliensis, L. peruviana, and their putative hybrids. At 24°C, the optimal temperature for in vitro growth, L. braziliensis had the highest growth rate.
Ler mais

Tongue nodules in canine leishmaniosis–a case report.

  • Autores: Albuquerque C, Campino L, Cardoso L, Dias I, Machado J, Pires MA, Requicha J, Sargo T, Viegas C
  • Ano de Publicação: 2012
  • Journal: Parasites & Vectors
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/22704596

BACKGROUND:
Canine leishmaniosis (CanL) caused by Leishmania infantum is an endemic zoonosis in southern European countries. Infected dogs can present rare or atypical forms of the disease and diagnosis can be challenging. The present report describes a case of tongue nodules in a 3-year-old neutered female Labrador Retriever dog with leishmaniosis.
Ler mais

Genetic isolation within the malaria mosquito Anopheles melas.

  • Autores: Athrey G, Caccone A, Costantini C, Deitz KC, Della Torre A, Jawara M, Kengne P, Kiszewski AE, Matias A, Overgaard HJ, Petrarca V, Pinto J, Reddy MR, Slotman MA
  • Ano de Publicação: 2012
  • Journal: Molecular Ecology
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/22882458

Anopheles melas is a brackish water-breeding member of the Anopheles gambiae complex that is distributed along the coast of West Africa and is a major malaria vector within its range. Because little is known about the population structure of this species, we analysed 15 microsatellite markers and 1161 bp of mtDNA in 11 A.
Ler mais

Gene flow-dependent genomic divergence between Anopheles gambiae M and S forms.

  • Autores: Donnelly MJ, Pinto J, Steen K, Weetman D, Wilding CS
  • Ano de Publicação: 2012
  • Journal: Molecular Biology and Evolution
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Gene+Flow-Dependent+Genomic+Divergence+between+Anopheles+gambiae+M+and+S+Forms.

Anopheles gambiae sensu stricto exists as two often-sympatric races termed the M and S molecular forms, characterized by fixed differences at an X-linked marker. Extreme divergence between M and S forms at pericentromeric “genomic islands” suggested that selection on variants therein could be driving interform divergence in the presence of ongoing gene flow, but recent work has detected much more widespread genomic differentiation.
Ler mais

Doxorubicin vs. ladirubicin: methods for improving osteosarcoma treatment.

  • Autores: Borges JP, Dias SJ, Ferreira IM, Novo C, Soares PI
  • Ano de Publicação: 2012
  • Journal: Mini-Reviews in Medicinal Chemistry
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Doxorubicin+vs.+ladirubicin%3A+methods+for+improving+osteosarcoma+treatment

Osteosarcoma is the most common primary bone tumor in children and adolescents, with a 5-year disease free survival rate of 70%. Current chemotherapy regimens comprise a group of chemotherapeutic agents in which doxorubicin is included. However, tumor resistance to anthracyclines and cardiotoxicity are limiting factors for its usage.
Ler mais

Expression of Chikungunya virus-like particles.

  • Autores: A. Esteves, A. P. Alves de Matos, B. Matos, C. Correia, J. Piedade, R. A. Velez, R. Parreira
  • Ano de Publicação: 2012
  • Journal: Microscopy and Microanalysis
  • Link: https://www.researchgate.net/publication/259425775_Expression_of_Chikungunya_Virus-like_Particles

Chikungunya virus (CHIKV) is a mosquito-transmitted alphavirus responsible for painful disablingpolyarthritis, undergoing re-emergence in the Indian Ocean and the Asian continent[1]. Travelling and changing patterns of vector distribution, and abundance due to climate changes, make CHIKV a global threat without effective control strategies. One approach to reduce the CHIKV burden is the development of a vaccine. Virus-like particles (VLPs) are a safe and highly effective class of subunit vaccines that mimic the overall structure of virus particles. Accordingly, we aim to produce CHIKV VLPs in a baculovirus-insect cell system, well known for allowing high yields of recombinant protein expression, to be used as a vaccine preparation.
Ler mais

Gold on paper-paper platform for Au-nanoprobe TB detection.

  • Autores: Baptista PV, Barquinha P, Costa MN, Fortunato E, Inacio J, Jacob JM, Martins R, Santos DS, Veigas B, Viveiros M
  • Ano de Publicação: 2012
  • Journal: Lab on a Chip
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Gold+on+paper-paper+platform+for+Au-nanoprobe+TB+detection

Tuberculosis (TB) remains one of the most serious infectious diseases in the world and the rate of new cases continues to increase. The development of cheap and simple methodologies capable of identifying TB causing agents belonging to the Mycobacterium tuberculosis Complex (MTBC), at point-of-need, in particular in resource-poor countries where the main TB epidemics are observed, is of paramount relevance for the timely and effective diagnosis and management of patients.
Ler mais

Cytokine and Phenotypic Cell Profiles of Leishmania infantum Infection in the Dog.

  • Autores: Campino L, Maia C
  • Ano de Publicação: 2012
  • Journal: Journal of Tropical Medicine
  • Link: http://www.ncbi.nlm.nih.gov/pubmed/?term=Cytokine+and+phenotypic+cell+profiles+of+Leishmania+infantum+infection+in+the+dog.

Leishmaniasis has reemerged in recent years showing a wider geographic distribution and increased global incidence of human and canine disease than previously known. Dogs are the main domestic/peridomestic reservoir hosts of zoonotic visceral leishmaniasis caused by Leishmania infantum.
Ler mais

  • « Go to Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 10
  • Go to Next Page »

Footer

INSTITUTO DE HIGIENE E
MEDICINA TROPICAL
UNIVERSIDADE NOVA DE LISBOA
Rua da Junqueira, 100 1349-008 Lisboa
T +351 213652600
F +351 213 632 105
geral@ihmt.unl.pt

Consulta do Viajante e Medicina Tropical
T +351 213652630/90
medicina.viagens@ihmt.unl.pt

Ensino
Investigação
Medicina Tropical
Cooperação

Siga-nos

  • Facebook
  • LinkedIn
  • YouTube

Receber a “newsletter”

© Copyright 2022 IHMT-UNL Todos os Direitos Reservados.
  • Universidade Nova de Lisboa
  • Fundação para a Ciência e a Tecnologia

    Project UID/Multi/04413/2013